Nav1.7 as a chondrocyte regulator and therapeutic target for osteoarthritis
2024 · Nature · 97 citations
https://doi.org/10.1038/s41586-023-06888-7
A
Aubryanna Hettinghouse
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
51
Papers
1.5K
Citations
21
h-index
29
i10-index
Aubryanna Hettinghouse is an academic researcher from New York University. The author has contributed to research in topics: Amyotrophic Lateral Sclerosis Research & Lysosomal Storage Disorders Research & Osteoarthritis Treatment and Mechanisms. The author has an h-index of 21, co-authored 44 publications.
ORCID: 0000-0002-7596-6315Papers by this author
worksp204 Is Required for Canonical Lipopolysaccharide-induced TLR4 Signaling in Mice
2018 · EBioMedicine · 26 citations
https://doi.org/10.1016/j.ebiom.2018.02.012
In Vitro Physical and Functional Interaction Assays to Examine the Binding of Progranulin Derivative Atsttrin to TNFR2 and Its Anti-TNFα Activity
2020 · Methods in molecular biology · 10 citations
https://doi.org/10.1007/978-1-0716-1130-2_8
Progranulin mediates the onset of pristane induced systemic lupus erythematosus
2024 · Advances in Rheumatology · 3 citations
https://doi.org/10.1186/s42358-024-00405-8
Additional file 1 of Penfluridol targets acid sphingomyelinase to inhibit TNF signaling and is therapeutic against inflammatory autoimmune diseases
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.18739362
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat